UPL Limited Board to Consider Q2 FY27 Results on November 2
Ask Iris
UPL Limited will consider its unaudited consolidated and standalone financial results for Q2 and the first half of FY27 at a board meeting on November 2, 2026. The company has not disclosed Q2 numbers yet, making the scheduled announcement important after Q1 revenue rose 10% year on year to ₹10,181 crore.
When will UPL Limited announce Q2 FY27 results?
UPL Limited is scheduled to consider, approve and take on record its unaudited financial results for the quarter and half year ended September 30, 2026, on Monday, November 2. The company has stated that the board meeting will also consider the limited review reports to be issued by its statutory auditors.
The July-September period is UPL's Q2 FY27. The filing does not contain revenue, profit, margin, debt or other operating figures for that quarter. As a result, the market will need to wait for the board's formal results release before assessing the company's financial performance during the period.
UPL has also scheduled a conference call at 4:00 pm IST on November 2, after the results announcement. The company said the accompanying presentation will be made available through its investor website. It has provided dial-in access for participants in India and other regions.
The announcement follows UPL's closure of its trading window from September 30, 2026, in line with insider-trading compliance requirements while unaudited results for the quarter and half year were being finalised. Such closures restrict designated persons from trading in the company's securities during the specified period.
What did UPL Limited report in Q1 FY27?
UPL Limited reported Q1 FY27 revenue of ₹10,181 crore, a 10.5% increase from the year-earlier quarter and a 44.5% decline from the preceding quarter. The company attributed the year-on-year revenue growth to performance in its Advanta seeds and specialty chemicals businesses.
EBITDA for the quarter rose 15% year on year to ₹1,500 crore. The reported EBITDA margin was 14.7%, an improvement of 60 basis points from the comparable quarter a year earlier. UPL described the quarter as its seventh consecutive quarter of revenue and EBITDA growth.
The company reported profit after tax attributable to minority interest, or PATMI, of ₹10 crore for Q1 FY27, compared with a loss of ₹88 crore in Q1 FY26. This marked a return to a positive reported PATMI figure, although the profit remained small relative to the company's revenue base.
UPL also said net debt to EBITDA improved to 2.4 times. Separately, the company reported net debt of ₹23,649 crore, equivalent to about 56.5% of trailing-twelve-month revenue according to the disclosed data. The debt position remains a relevant measure for investors evaluating the pace of balance-sheet improvement.
What is driving UPL Limited's current operating performance?
UPL Limited has identified the Advanta seeds and specialty chemicals platforms as important contributors to growth. In Q1 FY27, it said these businesses supported the 10% year-on-year increase in consolidated revenue, while the group also recorded higher EBITDA.
The India crop-protection business reported EBITDA margin expansion of about 750 basis points during the quarter. UPL linked the improvement to product mix and new brand launches. It also noted that the approximately 30% EBITDA margin in the India business was partly seasonal and would normalise in Q2.
Management has said the full-year India business margin is still expected to be above the prior year's level of about 17%, supported by new brands and product-mix changes. The company also indicated that a strong Q2 for the India business would depend on favourable monsoon rainfall, which is relevant to crop-protection demand.
UPL's standalone business showed a different trend in Q1. Standalone revenue was ₹1,397 crore, down 15.8% from ₹1,660 crore in the corresponding quarter a year earlier. This underlines the importance of reviewing both consolidated and standalone disclosures when the Q2 results are released.
What should investors monitor in UPL Limited's Q2 FY27 announcement?
Investors will monitor whether UPL Limited maintains growth in revenue and EBITDA, and whether its margin improvement extends beyond the seasonally strong conditions cited in the India business. The Q2 disclosure will provide the first reported figures for the July-September period and half-year performance.
The company has retained its FY27 guidance for revenue growth of 7% to 11% and EBITDA growth of 10% to 14%. The results and management commentary may show how performance in the first half compares with those ranges, but the current filing does not provide any update or revision to this guidance.
Debt reduction and leverage will also remain key points. UPL reported net debt to EBITDA of 2.4 times in Q1 FY27, alongside net debt of ₹23,649 crore. Any changes in debt, cash generation or finance costs disclosed in Q2 will be relevant to assessing the company's financial position.
The investor call may also provide context on demand trends across crop protection, seeds and specialty chemicals. However, until the results are formally released, no conclusion can be drawn about Q2 revenue, profitability, margins or operational performance from the board-meeting notice alone.
How does the Q2 FY27 schedule affect UPL Limited shareholders?
The November 2 schedule gives shareholders a defined date for the company's next financial update. The board meeting and subsequent conference call are expected to provide the formal results, auditor review information and management discussion for the quarter and the six months ended September 30, 2026.
For investors, the key reference point is UPL's Q1 FY27 performance: ₹10,181 crore in revenue, ₹1,500 crore in EBITDA and ₹10 crore in PATMI. These figures followed year-on-year growth in revenue and EBITDA, while the company's debt balance and the expected normalisation of India margins remain important issues for the next update.
The results will also be relevant for participants following India's agricultural-input sector. UPL has said seeds, specialty chemicals, product mix, new brands and monsoon conditions influence parts of its business. The Q2 announcement should provide updated company-specific information on these operating factors without the need to infer performance from the current notice.
Conclusion
UPL Limited's November 2 board meeting is scheduled to approve Q2 and H1 FY27 financial results, followed by a conference call at 4:00 pm IST. No Q2 financial data has been disclosed in the filing, while the latest reported Q1 figures showed ₹10,181 crore revenue, ₹1,500 crore EBITDA and ₹10 crore PATMI.
The next items to watch are the formal Q2 and half-year revenue, EBITDA margin, profitability and debt disclosures, along with management's comments on FY27 guidance of 7% to 11% revenue growth and 10% to 14% EBITDA growth. Commentary on India business margins, monsoon-linked demand and leverage will also be relevant.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q2 Earnings Tracker